Endogenous cardiac stem cells for the treatment of heart failure
Tania Fuentes, Mary Kearns-Jonker Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA, USA Abstract: Stem cell-based therapies hold promise for regenerating the myocardium after injury. Recent data obtained from phase I clinical trials using endogenous...
Guardado en:
Autores principales: | Fuentes T, Kearns-Jonker M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b5d438189ee4e1ead5f97082098c0ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Failure of Y-27632 to improve the culture of adult human adipose-derived stem cells
por: Lamas NJ, et al.
Publicado: (2015) -
Association between Biomarkers of Oxidative Stress and Inflammation with Cardiac Necrosis and Heart Failure in Non-ST Segment Elevation Myocardial Infarction Patients and Various Degrees of Kidney Function
por: Stefanos Roumeliotis, et al.
Publicado: (2021) -
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
por: Thorsten R Doeppner, et al.
Publicado: (2010) -
Treatment of systemic sclerosis: potential role for stem cell transplantation
por: Wen Xiong, et al.
Publicado: (2009) -
Stem cell treatment for avascular necrosis of the femoral head: current perspectives
por: Houdek MT, et al.
Publicado: (2014)